These cancers typically present in older adults, usually in the fifth to sixth decades of life and demonstrate a male predominance.
Mantle cell lymphomas characteristically express high levels of cyclin D1 caused by an (11;14) translocation which involves the IgH locus on chromosome 14 and the cyclin D1 locus on chromosome 11. The resulting up-regulation of cyclin D1 promotes progression from G1 to the S phase during the cell cycle.
Mantle cell lymphomas characteristically express high levels of cyclin D1 caused by an (11;14) translocation which involves the IgH locus on chromosome 14 and the cyclin D1 locus on chromosome 11. The resulting up-regulation of cyclin D1 promotes progression from G1 to the S phase during the cell cycle.
Most tumors express B cell markers including CD19 and CD20. It is also usually CD5 positive, and this immunophenotype is present in 80% of mantle cell lymphomas. Usually, CD5 is a protein used to identify T-cell neoplasms, and is also present in CLL and hairy cell leukemia.
The CD5 marker typically indicates the lymphoma is more aggressive. Mantle cell lymphomas have a poor prognosis with median survival only 3-4 years. The lymphoma usually cannot be cured with conventional chemotherapy and most patients eventually succumb to organ dysfunction due to tumor infiltration.
Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.
*Average video play time: 2-3 minutes
Unforgettable characters with concise but impactful videos (2-4 min each)